Patent ID: 11896712
Assignee: VERSANTIS AG
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method for treating a metabolite toxicopathy in a patient in need thereof, comprising:
the step of administering a therapeutically effective amount of a liposome composition into the peritoneal cavity of said patient, wherein the pH within the liposomes differs from the pH in the peritoneal cavity, wherein the pH within the liposomes results in liposomes-encapsulated charged metabolite, wherein the metabolite toxicopathy is selected from the group consisting of hyperammonemia, argininosuccinic acidemia, hyperuricemia, isovaleric acidemia and propionic acidemia, and wherein the liposome composition comprises liposomes having a diameter size larger than 600 nm; and
the step of extracting the liposomes-encapsulated charged metabolite from the peritoneal cavity.